Bright Minds Biosciences Pty Ltd
3 clinical trials · Sponsor
◉ Watch Bright Minds Biosciences Pty Ltd
| Record | Firm | Date |
|---|---|---|
| A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome. (NCT07266324) | Bright Minds Biosciences Pty Ltd | 2026-01-01 |
| BMB-101 in Absence Epilepsy and DEE (NCT06401538) | Bright Minds Biosciences Pty Ltd | 2024-12-05 |
| A 3-Part Study to Evaluate the Safety, Tolerability, PK, and Food Effect of BMB-101 in Healthy Volunteers (NCT05397041) | Bright Minds Biosciences Pty Ltd | 2022-06-06 |
Track Bright Minds Biosciences Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.